Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.
Virgolini I, Patri P, Novotny C, Traub T, Leimer M, Füger B, Li SR, Angelberger P, Raderer M, Wogritsch S, Kurtaran A, Kletter K, Dudczak R. Virgolini I, et al. Among authors: traub t. Ann Oncol. 2001;12 Suppl 2:S41-5. doi: 10.1093/annonc/12.suppl_2.s41. Ann Oncol. 2001. PMID: 11762351 Free article.
Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type.
Raderer M, Traub T, Formanek M, Virgolini I, Osterreicher C, Fiebiger W, Penz M, Jäger U, Pont J, Chott A, Kurtaran A. Raderer M, et al. Among authors: traub t. Br J Cancer. 2001 Nov 16;85(10):1462-6. doi: 10.1054/bjoc.2001.2070. Br J Cancer. 2001. PMID: 11720429 Free PMC article. Clinical Trial.
Scintigraphic imaging of the adrenal glands.
Kurtaran A, Traub T, Shapiro B. Kurtaran A, et al. Among authors: traub t. Eur J Radiol. 2002 Feb;41(2):123-30. doi: 10.1016/s0720-048x(01)00442-9. Eur J Radiol. 2002. PMID: 11809541 Review.
New trends in peptide receptor radioligands.
Virgolini I, Traub T, Novotny C, Leimer M, Füger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Andreae F, Kurtaran A, Dudczak R. Virgolini I, et al. Among authors: traub t. Q J Nucl Med. 2001 Jun;45(2):153-9. Q J Nucl Med. 2001. PMID: 11476164 Review.
Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression.
Fiebiger WC, Scheithauer W, Traub T, Kurtaran A, Gedlicka C, Kornek GV, Virgolini I, Raderer M. Fiebiger WC, et al. Among authors: traub t. Scand J Gastroenterol. 2002 Feb;37(2):222-5. doi: 10.1080/003655202753416911. Scand J Gastroenterol. 2002. PMID: 11843061 Clinical Trial.
Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
Virgolini I, Traub T, Novotny C, Leimer M, Füger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Burggasser G, Andreae F, Kurtaran A, Dudczak R. Virgolini I, et al. Among authors: traub t. Curr Pharm Des. 2002;8(20):1781-807. doi: 10.2174/1381612023393756. Curr Pharm Des. 2002. PMID: 12171531 Review.
New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.
Virgolini I, Traub T, Leimer M, Novotny C, Pangerl T, Ofluoglu S, Halvadjieva E, Smith-Jones P, Flores J, Li SR, Angelberger P, Havlik E, Andreae F, Raderer M, Kurtaran A, Niederle B, Dudczak R. Virgolini I, et al. Among authors: traub t. Q J Nucl Med. 2000 Mar;44(1):50-8. Q J Nucl Med. 2000. PMID: 10932601 Review.
20 results